USC’s Keck School of Medicine partners with StemCardia to advance heart failure treatment

FHS
October 8, 2024
11:28 pm

The Keck School of Medicine of USC has launched a strategic collaboration with StemCardia, a biotechnology company, founded by a Keck School of Medicine faculty member, that develops cellular and genetic therapies to address heart failure.

Research identifies key stressors impacting midwives’ wellbeing

Research into stress among midwives has identified the most effective actions individual midwives and healthcare trusts can make to enhance wellbeing and reduce negative outcomes,

December 19, 2024

Evaluating ChatGPT for structured data extraction from clinical notes

Researchers evaluate the ability of ChatGPT to extract structured data from unstructured clinical notes.

May 6, 2024

Could preventative care save the future of the NHS? – Pharmaceutical Technology

“The National Health Service in England is in serious trouble” according to a landmark investigation by the Rt Hon Professor the Lord Darzi of Denham.[i]

October 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.